Cellnovo appoints Sorin and Baxter veteran as chairman
This article was originally published in Clinica
Executive Summary
UK start-up Cellnovo has appointed Eric Beard chairman. Mr Beard is currently a senior advisor to US investment firm The Carlyle Group. Between 2003 and 2008, he was president for cardiovascular device specialist Sorin Group's international operations, where he was involved with the acquisition of disposable cardiovascular device developer Gish Biomedical in 2010 (www.clinica.co.uk, 9 June 2010). Mr Beard went on to become president and CEO of Gish. Before joining Sorin, he worked for Baxter International for 28 years, where he was initially responsible for Baxter's renal products in various countries, before ultimately becoming president of Baxter EMEA, covering all of its business in Europe, the Middle East and Africa. London-based Cellnovo is developing a mobile diabetes management system, which it CE marked for sale in Europe in September.